Pulmonx (LUNG) Enterprise Value (2019 - 2025)

Pulmonx (LUNG) has 7 years of Enterprise Value data on file, last reported at -$69.8 million in Q4 2025.

• On a quarterly basis, Enterprise Value rose 31.27% year-over-year to -$69.8 million in Q4 2025; TTM through Dec 2025 was -$69.8 million, a 31.27% increase from a year earlier, with the FY2025 full-year figure at -$69.8 million, up 31.27% from the prior year.
• Enterprise Value for Q4 2025 stood at -$69.8 million, up from -$76.5 million in the prior quarter.
• Over the last five years, Enterprise Value for LUNG reached as high as -$69.8 million in Q4 2025 and fell as low as -$219.1 million in Q1 2021.
• Historically, Enterprise Value has averaged -$136.0 million across 5 years, with a median of -$126.1 million in 2023.
• Across the five-year window, Enterprise Value slumped 1248.85% in 2021 and surged 31.27% in 2025, its largest moves.
• Year by year, Enterprise Value stood at -$180.0 million in 2021, then grew by 21.61% to -$141.1 million in 2022, then gained by 17.03% to -$117.1 million in 2023, then gained by 13.34% to -$101.5 million in 2024, then jumped by 31.27% to -$69.8 million in 2025.
• Per Business Quant data, the three most recent Enterprise Value figures were -$69.8 million in Q4 2025, -$76.5 million in Q3 2025, and -$84.2 million in Q2 2025.